Pharma Science & Research

Summary : The p53 protein protects our cells from cancer and is an interesting target for cancer treatments. The problem is, however,…

People who gained immunity – either through vaccination or exposure – against the original strain of SARS-CoV-2, the virus that causes COVID-19,…

Synopsis : Nanomedicines – typically drugs hidden within nanoscopic fatty membranes (‘liposomes’) – have potential to transform chemotherapy treatments, improving drug delivery…

Synopsis : Nirsevimab has the potential to offer RSV protection for all infants, with a single dose showing 74.5 percent efficacy in…

Synopsis : Valneva’s single-shot chikungunya vaccine candidate, VLA1553, offered a very high level of seroprotection in all adults, including the elderly. The…

Summary : The safety and efficacy of fezolinetant is being evaluated in the Phase III trial of over 1,800 women seeking relief…

Summary : Trodelvy® (sacituzumab govitecan-hziy) was found to significantly reduce the risk of disease progression or death in certain breast cancer patients. Trodelvy® (sacituzumab…

Highlight Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) today announced that Shionogi has…

Summary : Roche’s Vabysmo is having a strong start with doctors, but it has a long way to go if it wants…

Summary : Gilead Sciences has a lot of its oncology ambitions riding on Trodelvy’s success beyond its existing approvals. While investors have…